These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8920810)

  • 1. Semiquantitative estimation of Shigella antigen-specific antibodies: correlation with disease severity during shigellosis.
    Islam D; Wretlind B; Hammarström L; Christensson B; Lindberg AA
    APMIS; 1996; 104(7-8):563-74. PubMed ID: 8920810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis.
    Islam D; Wretlind B; Ryd M; Lindberg AA; Christensson B
    Infect Immun; 1995 May; 63(5):2054-61. PubMed ID: 7729920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immune response in patients with dysentery.
    Ciznar I; Qadri F; Hoque S; Bin AA; Schultsz C; Bartkova G
    Adv Exp Med Biol; 1995; 371B():919-22. PubMed ID: 7502926
    [No Abstract]   [Full Text] [Related]  

  • 4. Shigella-specific IgA in saliva of children with bacillary dysentery.
    Schultsz C; Qadri F; Hossain SA; Ahmed F; Ciznar I
    FEMS Microbiol Immunol; 1992 Jan; 4(2):65-72. PubMed ID: 1547024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients.
    Li A; Rong ZC; Ekwall E; Forsum U; Lindberg AA
    Scand J Infect Dis; 1993; 25(5):569-77. PubMed ID: 8284641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines.
    Robin G; Keisari Y; Slepon R; Ashkenazi S; Cohen D
    Vaccine; 1999 Aug; 17(23-24):3109-15. PubMed ID: 10462247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.
    Cohen D; Orr N; Robin G; Slepon R; Ashkenazi S; Ashkenazi I; Shemer J
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):451-5. PubMed ID: 8807212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis.
    Phalipon A; Kaufmann M; Michetti P; Cavaillon JM; Huerre M; Sansonetti P; Kraehenbuhl JP
    J Exp Med; 1995 Sep; 182(3):769-78. PubMed ID: 7544397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis.
    Islam D; Veress B; Bardhan PK; Lindberg AA; Christensson B
    J Clin Pathol; 1997 Jun; 50(6):513-20. PubMed ID: 9378821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.
    Islam D; Bardhan PK; Lindberg AA; Christensson B
    Infect Immun; 1995 Aug; 63(8):2941-9. PubMed ID: 7622216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine.
    Clarkson KA; Talaat KR; Alaimo C; Martin P; Bourgeois AL; Dreyer A; Porter CK; Chakraborty S; Brubaker J; Elwood D; Frölich R; DeNearing B; Weerts HP; Feijoo B; Halpern J; Sack D; Riddle MS; Fonck VG; Kaminski RW
    EBioMedicine; 2021 Apr; 66():103308. PubMed ID: 33813141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and analysis of immunoreactive proteins of
    Singh KKB; Salleh MZ; Ahmed N; Yean Yean C; Ismail A
    PeerJ; 2024; 12():e17498. PubMed ID: 38827305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
    Levine MM; McEwen J; Losonsky G; Reymann M; Harari I; Brown JE; Taylor DN; Donohue-Rolfe A; Cohen D; Bennish M
    J Clin Microbiol; 1992 Jul; 30(7):1636-41. PubMed ID: 1629317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.
    Samandari T; Kotloff KL; Losonsky GA; Picking WD; Sansonetti PJ; Levine MM; Sztein MB
    J Immunol; 2000 Feb; 164(4):2221-32. PubMed ID: 10657678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shigella lipopolysaccharide antibodies in pediatric populations.
    Passwell JH; Freier S; Shor R; Farzam N; Block C; Lison M; Shiff E; Ashkenazi S
    Pediatr Infect Dis J; 1995 Oct; 14(10):859-65. PubMed ID: 8584312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome.
    Azim T; Qadri F; Ahmed S; Sarker MS; Halder RC; Hamadani J; Chowdhury A; Wahed MA; Salam MA; Albert MJ
    Clin Diagn Lab Immunol; 1996 Nov; 3(6):701-5. PubMed ID: 8914761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity.
    Rasolofo-Razanamparany V; Cassel-Beraud AM; Roux J; Sansonetti PJ; Phalipon A
    Infect Immun; 2001 Sep; 69(9):5230-4. PubMed ID: 11500390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed immunoassay to assess Shigella-specific antibody responses.
    Kaminski RW; Clarkson K; Kordis AA; Oaks EV
    J Immunol Methods; 2013 Jul; 393(1-2):18-29. PubMed ID: 23583496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
    Taylor DN; Trofa AC; Sadoff J; Chu C; Bryla D; Shiloach J; Cohen D; Ashkenazi S; Lerman Y; Egan W
    Infect Immun; 1993 Sep; 61(9):3678-87. PubMed ID: 8359890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot.
    Li A; Zhao CR; Ekwall E; Lindberg AA
    Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.